Nelson Dusetti.
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Nelson Dusetti.
Sep 17, 2024, 19:39 |
Blog
Nelson Dusetti: Is a la carte treatment possible for pancreatic adenocarcinoma?
Nelson Dusetti shared a post on LinkedIn: "Next week, an important event will take place in…
Sep 12, 2024, 17:36 |
Insight
Nelson Dusetti: A major advancement in transcriptomic signatures for predicting treatment sensitivity in pancreatic cancer
Nelson Dusetti shared on LinkedIn: "We are thrilled to announce a major advancement in transcriptomic…
Sep 9, 2024, 10:07 |
Insight
Nelson Dusetti: Grateful to Institut National Du Cancer for funding through the PRT-K 2024 program
Nelson Dusetti shared on X: “Grateful to Institut National Du Cancer for funding through the PRT-K…
Sep 8, 2024, 14:51 |
Blog
Nelson Dusetti: Understanding the cellular mechanisms that drive pancreatic cancer treatment resistance in advanced cases
Nelson Dusetti shared on LinkedIn: "We are deeply grateful to the National Cancer Institute for awarding…
Sep 5, 2024, 15:09 |
Blog
Nelson Dusetti: Promising therapeutic strategies for targeting mitochondrial metabolism in pancreatic cancer cells
Nelson Dusetti shared a post on LinkedIn: "Exciting new research from Pierre Cordelier’s team, which we…
Sep 1, 2024, 08:12 |
Insight
Enhancing post - operative treatment for pancreatic ductal adenocarcinoma through AI
Nelson Dusetti posted on X: “We are very grateful to Davide Melisi for the thoughtful…
Aug 30, 2024, 15:30 |
Insight
Davide Melisi: Predicting sensitivity to chemotherapeutic treatments in pancreatic cancer with AI
Davide Melisi, Associate Professor of Medical Oncology at University of Verona, shared a post on…
Aug 3, 2024, 12:34 |
Blog
Nelson Dusetti: Summary of plenary lectures presented by our team at European Pancreatic Club congress
Nelson Dusetti posted on LinkedIn: "I would like to thank Mayoly Laboratories and the Club…
Jul 24, 2024, 22:22 |
Insight
Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer
Nelson Dusetti shared a post on LinkedIn: "We are thrilled to announce one of the…
Jul 20, 2024, 21:00 |
Blog
Nelson Dusetti: We are grateful to INCa for funding our project - NeoPREDICT
Nelson Dusetti shared a post on LinkedIn: . "We are grateful to INCa for funding…
Jul 13, 2024, 04:51 |
Dialogues
ASCO24 Updates: Pancreas-View: AI-Powered Precision Medicine for Pancreatic Cancer Treatment
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 3, 2024, 07:07 |
Blog
The Pancreatic Cancer Team Marseille at the European Pancreatic Club 2024
Nelson Dusetti, Director of Research at CRCM, shared on LinkedIn: "Proud and happy to have…
Jul 2, 2024, 16:08 |
Blog
Nelson Dusetti: Clinic and Digital Personalized Medicine seminar at the University of Corte
Nelson Dusetti, Director of the Translational Research and Innovative Therapies department in Pancreatic Cancer team,…
Jun 22, 2024, 14:12 |
Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
All:
14
Posts:
1 - 100
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube